Stock listing

OTC:MDRX Veradigm Inc. Stock

Follow Veradigm Inc. into a list and get an email when it puts out news.

Share price · OTC:MDRX

$5.10 USD +0.10 (+2.0%)

Close on Nov 20, 2026

Past year +9.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.75 – $5.18 USDNov 20, 2026
Volume
67,628 sharesNov 20, 2026
Market cap
$555.9M USDAt the close on Nov 20, 2026 · price × 109.0M shares outstanding
52-week range
$3.25 – $5.60 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$409,268 USDMedian day 11,997 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Veradigm Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:MDRX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$5.10+0.10+2.0%$5.18$5.18$4.7567,628
$5.000.000.0%$4.99$5.00$4.991,214
$5.00-0.18-3.5%$4.50$5.00$4.50651
$5.18+0.18+3.6%$5.18$5.18$5.181,313
$5.00+0.025+0.5%$4.75$5.00$4.7558,628
$4.975+0.225+4.7%$4.975$4.975$4.9751,195
$4.750.000.0%$4.75$4.75$4.7542,682
$4.750.000.0%$4.95$4.95$4.7511,997
$4.75-0.05-1.0%$4.95$4.95$4.753,183
$4.80-0.10-2.0%$4.925$4.95$4.7546,421
$4.90-0.025-0.5%$4.78$4.90$4.781,483
$4.925+0.175+3.7%$4.925$4.925$4.9251,272
$4.75-0.20-4.0%$3.45$4.95$3.452,480
$4.95-0.05-1.0%$4.755$4.95$4.757,108
$5.00+0.25+5.3%$4.76$5.00$4.75102,500
$4.75-0.25-5.0%$4.75$4.75$4.751,500
$5.00+0.25+5.3%$4.98$5.00$4.951,600
$4.750.000.0%$4.98$4.98$4.75496,600
$4.75-0.20-4.0%$5.00$5.00$4.75502,300
$4.95+0.05+1.0%$4.75$4.95$4.7547,800
$4.90+0.15+3.2%$4.75$4.90$4.7547,100
$4.750.000.0%$5.00$5.00$4.7527,100
$4.75-0.25-5.0%$4.755$4.755$4.001,023,324
$5.000.000.0%$5.00$5.00$4.7520,796
$5.000.000.0%$5.00$5.00$4.7539,700
$5.000.000.0%$5.00$5.00$5.00800
$5.000.000.0%$5.00$5.00$5.001,800
$5.00-0.065-1.3%$4.75$5.00$4.755,300
$5.065-0.025-0.5%$4.75$5.065$4.751,502
$5.09+0.09+1.8%$4.60$5.09$4.6097,200
$5.000.000.0%$4.75$5.00$4.752,200
$5.000.000.0%$4.75$5.00$4.7526,500
$5.000.000.0%$5.00$5.00$4.751,606
$5.000.000.0%$4.50$5.00$4.0010,142
$5.000.000.0%$5.14$5.14$4.7526,100
$5.00-0.14-2.7%$5.00$5.00$4.7526,000
$5.14+0.14+2.8%$5.10$5.14$4.7569,400
$5.00-0.05-1.0%$5.10$5.10$4.006,298
$5.05+0.05+1.0%$4.85$5.05$4.7554,568
$5.00+0.05+1.0%$4.60$5.03$4.6012,300
$4.95+0.14+2.9%$4.90$5.03$4.651,158,700
$4.81-0.04-0.8%$4.60$4.90$4.604,000
$4.850.000.0%$4.85$4.85$4.850
$4.85+0.15+3.2%$4.88$4.88$4.817,400
$4.70-0.10-2.1%$4.60$4.88$4.6025,500
$4.80-0.08-1.6%$4.61$4.80$4.616,900
$4.88+0.02+0.4%$4.90$4.90$4.6057,600
$4.86+0.009+0.2%$4.60$4.90$4.6050,605
$4.851+0.251+5.5%$4.895$4.90$4.7749,631
$4.60+0.05+1.1%$4.56$4.65$4.55257,200
$4.55-0.10-2.2%$4.65$4.70$4.55111,400
$4.65-0.20-4.1%$4.65$4.80$4.655,000
$4.85+0.04+0.8%$4.00$4.875$4.00770
$4.81+0.01+0.2%$4.85$4.85$4.8032,463
$4.80+0.10+2.1%$4.70$4.88$4.651,900
$4.70-0.105-2.2%$4.90$4.90$4.70841
$4.805+0.004+0.1%$4.88$4.88$4.8056,305
$4.801-0.099-2.0%$4.75$4.90$4.7164,262
$4.90+0.09+1.9%$4.88$4.90$4.65323,611
$4.81-0.07-1.4%$4.65$4.90$4.652,099
$4.88+0.08+1.7%$4.65$4.88$4.652,281
$4.80-0.10-2.0%$4.80$4.85$4.753,975
$4.90-0.07-1.4%$4.65$4.985$4.65352,029
$4.97+0.02+0.4%$4.75$5.00$4.7563,036
$4.95-0.01-0.2%$4.75$4.99$4.754,400
Ticker
OTC:MDRX
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
OTC
Currency
USD

What changed lately

Latest news

All Veradigm Inc. news

Veradigm Inc. on 6ix

Sector
Health care
Industry
Health care services
News releases
2 in the last 12 months · 2 in all · newest Oct 21, 2026 · oldest 2026
Decks
57 decks · latest Sep 15, 2026

Valuation

price Nov 20, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
-0.30

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Veradigm Inc. · OTC:MDRXUS$555.9Mn/an/an/an/an/an/an/a-0.30
Artemis Medicare Services Ltd. · NSE:ARTEMISMEDUS$582.2MUS$582.2Mn/an/an/a5.7×n/a0.0×n/a
Medlive Technology Co., Ltd. · HKEX:2192US$581.7MUS$184.1M11.6×1.9×10.9×0.8×52.1%0.0×n/a
NRC Health · NASDAQ:NRCUS$556.5MUS$655.8M90.8×4.6×26.9×n/a4.3%n/a0.74
PT Famon Awal Bros Sedaya Tbk · IDX:PRAYUS$554.2MUS$632.0M54.8×4.2×19.5×3.1×6.7%0.6×n/a
Chularat Hospital PCL · SET:CHGUS$550.6MUS$527.6M19.2×2.1×10.4×2.4×11.5%0.1×n/a
GMR Solutions Inc. · NYSE:GMRSUS$546.7MUS$4.44B2.6×0.8×3.9×0.6×3.6%4.7×0.24
Heren Health Co., Ltd. Class A · SZSE:300550US$539.5MUS$475.3Mn/a8.2×n/a3.3×−7.2%0.0×n/a
SBC Medical Group Holdings Incorporated · NASDAQ:SBCUS$531.7MUS$366.6M10.3×1.9×4.7×1.9×27.3%0.1×1.20
Sophia Genetics SA · NASDAQ:SOPHUS$530.3MUS$497.7Mn/a5.5×n/a7.8×−89.2%0.9×1.74
Vibhavadi Medical Center Public Co. Ltd. · SET:VIBHAUS$520.2MUS$584.8M9.6×4.8×22.7×1.6×44.3%0.3×n/a
Median of the othersUS$548.7MUS$554.9M11.6×4.2×10.9×2.4×6.7%0.1×0.97

Forecasts

1 strong buy · 2 hold · Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.

Price target
8.00 USD · Analysts' mean
EPS, year to Dec 2025
0.25 · 1 analyst

Team and board

Officers

OfficerRole
Don TriggChief Executive Officer
Christian GreyenbuhlChief Financial Officer
Lisa MarchlewiczSenior Vice President of Real-World Evidence

Board

DirectorRole
Bruce FeltBoard Member
Carol ZierhofferBoard Member
Dave Stevens
Don TriggChief Executive Officer
Jonathan SacksBoard Member
Louis SilvermanBoard Member
Susan RodriguezBoard Member
Vinit AsarBoard Member

Events

QuarterResultsShare move
Quarter to Mar 31, 2026May 26, 2026 · After close+3.2%
Quarter to Dec 31, 2025Feb 27, 20260.0%
Quarter to Sep 30, 2025Nov 7, 2025−5.0%
Quarter to Jun 30, 2025Aug 8, 2025−2.1%
Quarter to Mar 31, 2025May 9, 2025−6.5%
Q4 2024Mar 17, 2025 · After close+0.6%
Quarter to Sep 30, 2024Nov 1, 20240.0%
Quarter to Jun 30, 2024Aug 2, 2024−3.9%
Quarter to Mar 31, 2024May 3, 2024−1.3%
Quarter to Dec 31, 2023Mar 13, 2024 · After close+3.7%
All 20 quarters
QuarterResultsShare move
Q3 2023Oct 20, 2023 · After close−0.5%
Q2 2023Sep 29, 2023 · Before open−1.8%
Q1 2023May 10, 2023 · After close−0.2%
Q4 2022Mar 1, 2023 · After close−0.9%
Q3 2022Nov 3, 2022 · After close+12.7%
Q2 2022Aug 4, 2022 · After close+13.5%
Q1 2022May 5, 2022 · After close−6.2%
Q4 2021Feb 24, 2022 · After close−4.2%
Q3 2021Nov 4, 2021 · After close+6.6%
Q2 2021Aug 5, 2021 · After close+1.5%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2026)Investor deck20 slidesSep 15, 2026
Barclays Healthcare Investor Conference 2024Conference11 slidesMar 13, 2024
JP Morgan Healthcare Conference 2024Conference31 slidesJan 10, 2024
J.P. Morgan Healthcare Conference 2023Conference30 slidesJan 11, 2023
Allscripts Healthcare Solutions — Investor Day (September 2022)Investor day57 slidesSep 28, 2022
Allscripts Healthcare Solutions — Merger or Acquisition (March 2022)Merger or acquisition14 slidesMar 3, 2022
Allscripts Healthcare Solutions — J.P. Morgan Virtual Healthcare Conference 2021Conference16 slidesJan 12, 2021
Allscripts Healthcare Solutions — Q2 2020 Earnings PresentationEarnings20 slidesJul 31, 2020
Allscripts Healthcare Solutions — J.P. Morgan Healthcare Conference 2020Conference23 slidesJan 14, 2020
Allscripts Healthcare Solutions — J.P. Morgan Healthcare Conference 2019Conference24 slidesJan 7, 2019
Show 50 decks
DeckKindSlidesDate
Allscripts Healthcare Solutions — J.P. Morgan 2018 Healthcare ConferenceConference27 slidesJan 9, 2018
Allscripts Healthcare Solutions — Investor Day (March 2017)Investor day180 slidesMar 21, 2017
Allscripts Healthcare Solutions — J.P. Morgan 2017 Healthcare ConferenceConference31 slidesJan 10, 2017
Allscripts Healthcare Solutions — 34th Annual J.P. Morgan Healthcare Conference (January 2016)Conference41 slidesJan 12, 2016
Allscripts Healthcare Solutions — J.P. Morgan Healthcare Conference 2014Conference35 slidesJan 14, 2014
Allscripts Healthcare Solutions — Investor Presentation (June 2013)Investor deck38 slidesJun 12, 2013
Allscripts Healthcare Solutions — Investor Presentation (May 2012)Investor deck48 slidesMay 8, 2012
Allscripts Healthcare Solutions — J.P. Morgan Annual Healthcare Conference (January 2012)Conference149 slidesJan 10, 2012
Allscripts Healthcare Solutions — William Blair & Company Growth Stock Conference 2011Conference32 slidesJun 15, 2011
Allscripts Healthcare Solutions — Investor Presentation (March 2011)Investor deck34 slidesMar 2, 2011
Allscripts Healthcare Solutions — Investor Presentation (November 2010)Investor deck30 slidesNov 10, 2010
Allscripts Healthcare Solutions — Investor Presentation (September 2010)Investor deck30 slidesSep 27, 2010
Allscripts-Misys Healthcare Solutions — Investor Presentation (April 2010)Investor deck47 slidesApr 13, 2010
Allscripts-Misys Healthcare Solutions — Investor Presentation (January 2010)Investor deck42 slidesJan 26, 2010
Allscripts-Misys Healthcare Solutions — Investor Presentation (January 2010)Investor deck36 slidesJan 13, 2010
Allscripts-Misys Healthcare Solutions — Investor Presentation (October 2009)Investor deck25 slidesOct 5, 2009
Allscripts-Misys Healthcare Solutions — Investor Presentation (July 2009)Investor deck27 slidesJul 22, 2009
Allscripts-Misys Healthcare Solutions — Investor Presentation (April 2009)Investor deck23 slidesApr 24, 2009
Allscripts-Misys Healthcare Solutions — Investor Presentation (April 2009)Investor deck22 slidesApr 7, 2009
Allscripts-Misys Healthcare Solutions — Investor Presentation (January 2009)Investor deck22 slidesJan 12, 2009
Allscripts-Misys Healthcare Solutions — Investor Presentation (October 2008)Investor deck27 slidesOct 23, 2008
Allscripts Healthcare Solutions — Merger or Acquisition (March 2008)Merger or acquisition25 slidesMar 27, 2008
Allscripts Healthcare Solutions — Merger or Acquisition (March 2008)Merger or acquisition36 slidesMar 18, 2008
Allscripts Healthcare Solutions — Investor Presentation (February 2008)Investor deck38 slidesFeb 26, 2008
Allscripts Healthcare Solutions — Investor Presentation (November 2007)Investor deck34 slidesNov 13, 2007
Allscripts Healthcare Solutions — Investor Presentation (August 2007)Investor deck35 slidesAug 28, 2007
Allscripts Healthcare Solutions — Investor Presentation (May 2007)Investor deck34 slidesMay 17, 2007
Allscripts Healthcare Solutions — Investor Presentation (February 2007)Investor deck34 slidesFeb 28, 2007
Allscripts Healthcare Solutions — Investor Day (October 2006)Investor day29 slidesOct 18, 2006
Allscripts Healthcare Solutions — Investor Presentation (October 2006)Investor deck35 slidesOct 18, 2006
Allscripts Healthcare Solutions — Investor Presentation (August 2006)Investor deck32 slidesAug 7, 2006
Allscripts Healthcare Solutions — Investor Day (August 2006)Investor day31 slidesAug 3, 2006
Allscripts Healthcare Solutions — Investor Presentation (May 2006)Investor deck31 slidesMay 9, 2006
Allscripts Healthcare Solutions — Investor Presentation (March 2006)Investor deck44 slidesMar 2, 2006
Allscripts Healthcare Solutions — Investor Day (February 2006)Investor day32 slidesFeb 14, 2006
Allscripts Healthcare Solutions — Investor Presentation (November 2005)Investor deck33 slidesNov 23, 2005
Allscripts Healthcare Solutions — Investor Day (November 2005)Investor day32 slidesNov 15, 2005
Allscripts Healthcare Solutions — Investor Day (September 2005)Investor day21 slidesSep 8, 2005
Allscripts Healthcare Solutions — Investor Day (September 2005)Investor day11 slidesSep 8, 2005
Allscripts Healthcare Solutions — Investor Day (September 2005)Investor day9 slidesSep 8, 2005

This page holds 50 of 57 decks. Open Decks

Open Decks

Financials

Annual, in USD

Income statement

LineFY2024FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue588.0M588.0M577.4M1.50B1.63B1.75B1.50B1.55B1.39B1.38B
Cost of revenue279.6M279.6M319.3M937.0M1.06B1.03B864.9M904.9M829.0M831.9M
Gross profit308.4M308.4M258.2M565.7M574.5M724.5M632.8M645.0M557.4M546.0M
Research and development97.9M97.9M84.8M206.1M254.5M295.8M220.2M188.1M184.8M192.8M
Selling, general and administrative169.2M313.8M389.9M419.8M451.0M486.3M392.9M339.2M358.7M
Operating income-27.1M-19.6M75.7M-57.7M-99.7M-95.1M12.5M67.7M31.9M-39.2M
Depreciation and amortization115.9M115.9M72.8M87.2M250.6M192.3M157.3M136.3M161.0M174.3M
EBITDA88.8M96.4M148.4M29.5M150.9M97.2M169.8M204.0M192.9M135.1M
Interest expense6.35M6.35M13.2M34.3M43.2M50.9M37.5M29.5M30.0M29.3M
Income before tax-63.9M-63.9M157.7M-149.3M-281.8M-62.2M-190.0M31.6M570.0K-68.1M
Income tax-43.8M27.9M-16.7M-43.3M-19.0M-5.51M309.0K2.63M-1.66M
Net income-86.5M-86.5M134.4M700.4M-182.2M363.7M-196.5M-25.7M-2.23M-66.5M
Earnings per share, basic-0.67-0.670.974.40-1.102.04-1.09-0.14-0.01-0.37

Balance sheet

LineFY2024FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash and equivalents446.6M446.6M188.3M531.1M129.6M174.2M119.5M95.6M116.9M53.2M
Short-term investments51.0K68.0K6.66M29.6M018.8M
Receivables175.7M119.1M451.9M479.5M517.7M531.7M492.6M405.2M327.8M331.6M
Inventory118.8M139.3M153.9M111-22.0K137.9M
Current assets679.6M679.6M761.3M1.15B841.3M859.0M857.1M604.3M538.3M487.2M
Property, plant and equipment47.9M72.2M88.3M121.9M165.6M148.8M125.6M145.8M
Goodwill532.6M532.6M974.5M974.7M974.1M1.37B1.29B1.92B1.22B1.20B
Total assets1.50B1.50B2.43B2.92B3.21B3.18B4.23B3.83B2.68B2.46B
Accounts payable30.8M30.8M6.20M35.9M102.8M73.2M85.7M126.1M60.0M70.8M
Current liabilities230.3M230.3M488.4M934.8M1.21B797.7M889.6M667.1M512.9M521.4M
Long-term debt200.4M350.1M167.6M551.0M647.5M906.7M717.9M612.4M548.7M
Total debt219.4M372.9M283.3M1.03B669.4M937.9M1.33B625.0M566.7M
Total liabilities487.2M487.2M1.02B1.25B1.92B1.60B2.64B2.17B1.26B1.18B
Shareholders' equity1.02B1.02B1.41B1.67B1.29B1.58B1.12B1.23B1.42B1.28B
Shares outstanding128.9M128.9M138.7M159.3M166.3M178.5M180.8M186.2M185.1M179.8M

Cash flow

LineFY2024FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations115.6M115.6M-75.4M-106.7M46.3M67.9M279.4M269.0M211.6M103.5M
Capital spending-32.3M-32.3M-1.89M-17.0M-128.0M-144.6M-157.0M-137.9M-67.6M-67.1M
Free cash flow83.3M83.3M-78.5M-123.7M-84.2M-76.7M122.4M131.1M144.0M36.4M
Cash from investing585.1M-12.2M1.62B-161.1M248.0M-413.0M-1.15B-289.0M-108.7M
Cash from financing-444.9M-444.9M-258.9M-1.11B67.3M-293.0M198.6M865.3M142.3M-4.28M
Dividends paid-580.2M-374.7M-1.16B00
Share buybacks-234.4M-234.4M-417.4M-334.1M-111.5M-138.9M-12.1M-121.2M-7.06K-10.4K
Change in cash256.2M256.2M-347.0M399.9M-47.3M22.3M65.9M-20.3M63.7M-9.78M

Open Financials

Cap table

Built by 6ix from Veradigm Inc.’s releases

Common shares
108,990,678
Fully diluted
108,990,678

Fully diluted

LineShares
Common shares108,990,678

Share count over time

CountShares
Nov 22, 2026108,990,678

Open Cap table

Shareholders

HolderSharesOf the companyValueAs of
FNY Investment Advisers, LLC13,0000.01%US$66Sep 30, 2026
Up Capital Management, Inc.379<0.01%US$1,948Sep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Susan Rodriguez
Other companies: Monopar Therapeutics Inc. (Chief Commercial and Strategy Officer · Since at least Mar 2, 2026); Avadel Pharmaceuticals PLC (Chief Operating Officer · Since at least May 13, 2025); Heron Therapeutics, Inc. (Director · Sep 20, 2021 – Jan 31, 2025 · Past); Ardelyx, Inc. (Chief Commercial Officer · May 18, 2020 – May 21, 2024 · Past)
Director · Since at least Feb 17, 2023
Louis E. Silverman
Other companies: STAAR Surgical Company (Director · Since at least Apr 24, 2025); Insight Molecular Diagnostics Inc. (Director · Since at least Jul 1, 2024)
Director · Since at least Feb 20, 2025
Carol Zierhoffer
Other companies: Atlas Air Worldwide Holdings Inc (Director · May 25, 2021 – Mar 17, 2023 · Past)
Board Member · Since at least May 31, 2024
Vinit Asar
Other companies: ZimVie Inc (Director · Since at least May 7, 2025)
Director · Since at least Jun 2, 2025
Bruce C Felt JrDirector · Since at least Mar 19, 2025
Bruce FeltBoard Member · Since at least Nov 5, 2026
Christian GreyenbuhlChief Financial Officer · Since at least Apr 6, 2026
Dave StevensDirector · Since at least Nov 4, 2026
Don TriggChief Executive Officer · Since at least Nov 4, 2026
Greg GarrisonExecuitive Chairman · May 31, 2024 – May 31, 2024 · Past
All 18 people
PersonSeat
John MotulskyDirector · Since at least May 31, 2025
Jonathan SacksBoard Member · Since at least Nov 5, 2026
Leah JonesChief Financial Officer · Apr 1, 2023 – May 1, 2023 · Past
Leland WesterfieldCFO · Jan 1, 2024 – May 31, 2024 · Past
Lisa MarchlewiczSenior Vice President of Real-World Evidence · Since at least Nov 4, 2026
Richard J PoultonCEO, Director · Feb 15, 2023 – Aug 4, 2023 · Past
Tejal VakhariaSVP General Counsel · Since at least Feb 26, 2024
Thomas LanganCEO · Apr 1, 2025 – May 2, 2025 · Past

Open People

Log in to ask 6ix AI your own questions about Veradigm Inc.